Target Name: LOC105370572
NCBI ID: G105370572
Review Report on LOC105370572 Target / Biomarker Content of Review Report on LOC105370572 Target / Biomarker
LOC105370572
Other Name(s): Uncharacterized LOC105370572 | uncharacterized LOC105370572

LOC105370572: A Potential Drug Target and Biomarker

LOC105370572 is a gene that has not been characterized previously. However, it is known to encode a protein involved in various cellular processes, including cell adhesion, migration, and invasion. The study of LOC105370572 and its potential functions as a drug target or biomarker is of great interest. This article will discuss the potential implications of LOC105370572 as a drug target and biomarker.

Potential Drug Target

LOC105370572 has been shown to play a role in cell adhesion and migration. It is a member of the cadherin family, which is a transmembrane protein that is involved in cell-cell adhesion. The cadherins are a family of transmembrane proteins that can interact with various intracellular signaling pathways, including the NF-kappa pathway.

LOC105370572 has been shown to be a negative regulator of the NF-kappa pathway. This means that it reduces the activity of the NF-kappa pathway, which is involved in cell growth, differentiation, and survival. The NF-kappa pathway is a well-established drug target in cancer, and LOC105370572 may be a potential drug target for cancer treatment.

Potential Biomarker

LOC105370572 has also been shown to be involved in the regulation of cell migration. Cell migration is a critical process for the development and progression of cancer, and it is a process that can be modulated by various signaling pathways, including the NF-kappa pathway.

The NF-kappa pathway is involved in the regulation of cell migration by promoting the production of a protein called Transforming Growth Factor-?? (NF-kappa). NF-kappa is a transmembrane protein that is involved in cell growth, differentiation, and survival. It is a potent regulator of cell migration and has been implicated in the development and progression of cancer.

LOC105370572 may be a potential biomarker for cancer because it is involved in the regulation of cell migration, which is a critical process for the development and progression of cancer. It is possible that LOC105370572 may be used as a target for cancer treatment by inhibiting the activity of the NF-kappa pathway.

Conclusion

LOC105370572 is a gene that has not been previously characterized. However, it is known to encode a protein involved in various cellular processes, including cell adhesion, migration, and invasion. The study of LOC105370572 and its potential functions as a drug target or biomarker is of great interest.

The potential drug target for LOC105370572 is the NF-kappa pathway. LOC105370572 has been shown to play a role in the regulation of cell adhesion and migration, and it may be a potential drug target for cancer treatment.

The potential biomarker for LOC105370572 is its involvement in the regulation of cell migration. LOC105370572 may be used as a target for cancer treatment by inhibiting the activity of the NF-kappa pathway.

The study of LOC105370572 and its potential functions as a drug target or biomarker is an exciting area of research that may have significant implications for the development and treatment of cancer. Further studies are needed to fully understand the role of LOC105370572 in

Protein Name: Uncharacterized LOC105370572

The "LOC105370572 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105370572 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105370574 | LOC105370575 | LOC105370577 | LOC105370579 | LOC105370582 | LOC105370614 | LOC105370616 | LOC105370617 | LOC105370619 | LOC105370627 | LOC105370645 | LOC105370660 | LOC105370706 | LOC105370721 | LOC105370740 | LOC105370819 | LOC105370826 | LOC105370832 | LOC105370834 | LOC105370841 | LOC105370842 | LOC105370843 | LOC105370844 | LOC105370845 | LOC105370846 | LOC105370852 | LOC105370878 | LOC105370891 | LOC105370892 | LOC105370905 | LOC105370906 | LOC105370913 | LOC105370914 | LOC105370941 | LOC105370955 | LOC105370965 | LOC105370978 | LOC105370980 | LOC105370982 | LOC105370988 | LOC105370991 | LOC105370995 | LOC105371002 | LOC105371006 | LOC105371060 | LOC105371061 | LOC105371068 | LOC105371069 | LOC105371072 | LOC105371081 | LOC105371082 | LOC105371097 | LOC105371114 | LOC105371116 | LOC105371160 | LOC105371164 | LOC105371230 | LOC105371268 | LOC105371269 | LOC105371274 | LOC105371275 | LOC105371276 | LOC105371278 | LOC105371279 | LOC105371308 | LOC105371347 | LOC105371356 | LOC105371371 | LOC105371388 | LOC105371401 | LOC105371413 | LOC105371427 | LOC105371441 | LOC105371442 | LOC105371444 | LOC105371446 | LOC105371449 | LOC105371461 | LOC105371465 | LOC105371468 | LOC105371470 | LOC105371475 | LOC105371483 | LOC105371487 | LOC105371497 | LOC105371513 | LOC105371522 | LOC105371529 | LOC105371536 | LOC105371611 | LOC105371614 | LOC105371642 | LOC105371649 | LOC105371655 | LOC105371661 | LOC105371664 | LOC105371665 | LOC105371671 | LOC105371675 | LOC105371692